The novel approach of this peptide represents a major development in the handling of the condition. Different to existing therapies, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide066066.activoblog.com/54171358/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment